Physician profile
Derek P Watson
NPI 1255524435
$2,252.51
in general payments reported to CMS, 2019-2025
11 companies · $737 in 2025
The $737 reported for 2025 was more than what 84% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $71.66 · 2021: $230 · 2022: $162 · 2023: $701 · 2024: $182 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,394 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.06 |
| Travel and Lodging | $226.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $709.93 | 2025 | Intracept, Wavewriter Alpha Prime 16 |
| Relievant Medsystems, INC. | $614.55 | 2023 | Intracept |
| Nevro Corp. | $381.76 | 2019-2024 | Senza |
| Si-Bone, INC. | $157.94 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $123.09 | 2019-2020 | |
| Pacira Therapeutics, INC. | $99.86 | 2019-2020 | |
| Medtronic, INC. | $47.69 | 2022-2023 | Intellis Adaptivestim |
| Fidia Pharma USA INC. | $43.03 | 2023 | Hymovis, Triluron |
| Globus Medical, INC. | $27.33 | 2025 | Senza |
| Medline Industries LP | $25.56 | 2024 | Medline Industries, INC. |
| Pacira Pharmaceuticals Incorporated | $21.77 | 2024 | Exparel, Zilretta, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.